A significant proportion of stroke patients discontinue secondary prevention medications within 1 year, highlighting the need to target modifiable factors to improve adherence.
Clinicians should monitor post-stroke medication persistence closely in year 1; this cohort study leaves open which interventions best improve adherence.
Although up to one-third of stroke patients discontinued one or more secondary prevention medications within 1 year of hospital discharge, self-discontinuation of these medications is uncommon. Several potentially modifiable patient, provider, and system-level factors associated with persistence and adherence may be targets for future interventions.
No takes yet. Share an insight, caveat, or question.
Bushnell et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: